Iovance Biotherapeutics (IOVA) EBITDA (2010 - 2026)
Iovance Biotherapeutics (IOVA) reported EBITDA of -$42.41 million for Q2 2026, compared with -$104.67 million a year earlier.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) EBITDA (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Iovance Biotherapeutics' EBITDA came in at -$264.38 million; for FY2025, it came in at -$367.42 million.
- By year, EBITDA came in at -$357.64 million in FY2024, -$439.14 million in FY2023, -$389.57 million in FY2022 and -$339.59 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBITDA since Q1 2019.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$72.5 million (Q1 2026), -$63.56 million (Q4 2025) and -$85.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | -14.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -14.47 Mn |
| Jun 30, 2026 | -42.41 Mn |
| Mar 31, 2026 | -72.50 Mn |
| Dec 31, 2025 | -63.53 Mn |
| Sep 30, 2025 | -85.91 Mn |
| Jun 30, 2025 | -104.67 Mn |
| Mar 31, 2025 | -113.16 Mn |
| Dec 31, 2024 | -72.62 Mn |
| Sep 30, 2024 | -80.57 Mn |
| Jun 30, 2024 | -93.41 Mn |
| Mar 31, 2024 | -110.09 Mn |
| Dec 31, 2023 | -114.40 Mn |
| Sep 30, 2023 | -111.46 Mn |
| Jun 30, 2023 | -105.29 Mn |
| Mar 31, 2023 | -108.06 Mn |
| Dec 31, 2022 | -104.23 Mn |
| Sep 30, 2022 | -97.90 Mn |
| Jun 30, 2022 | -97.53 Mn |
| Mar 31, 2022 | -89.92 Mn |
| Dec 31, 2021 | -97.28 Mn |
API Access
Iovance Biotherapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();